Targeting All Multiple Magnetic Resonance Imaging Prostate Lesions Does Not Enhance Cancer Detection: Insights from the YAU Prostate Cancer Group
Fabio Zattoni, Giacomo Novara(University of Padua), Fabrizio Moro(University of Padua), Alessandro Marquis(Azienda Ospedaliero Universitaria San Giovanni Battista), Roderick van den Bergh(European Association of Urology), Claudia Kesch(Essen University Hospital), Filippo Carletti(University of Padua), Francesco Barletta(Vita-Salute San Raffaele University), Junlong Zhuang(Nanjing Drum Tower Hospital), Tamás Fazekas(Semmelweis University), Alberto Briganti(University College London Hospitals NHS Foundation Trust), Alberto Martini(The University of Texas MD Anderson Cancer Center), Maria Apfelbeck(LMU Klinikum), Hongqian Guo(Nanjing Drum Tower Hospital), Massimo Valério(University Hospital of Geneva), Peter Ka‐Fung Chiu(Chinese University of Hong Kong), Giorgio Gandaglia(European School of Oncology), Alexander Kretschmer(Ludwig-Maximilians-Universität München), Giancarlo Marra(Azienda Ospedaliero Universitaria San Giovanni Battista), Riccardo Leni(Vita-Salute San Raffaele University), Jonathan Olivier(Université de Lille), Guillaume Ploussard(Clinique Saint Jean Languedoc), Paolo Gontero, Francesco Giganti(University College London Hospitals NHS Foundation Trust), Giuseppe Ottone Cirulli(Istituti di Ricovero e Cura a Carattere Scientifico), Veeru Kasivisvanathan(University College London), Paweł Rajwa(University College London)
Cited by 5
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study
|The Lancet Oncology|2024|305
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
|Annals of the Rheumatic Diseases|2001|287
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
|Journal of Clinical Oncology|2020|280